Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 4

Status

Completed 3Unknown 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 6UNKNOWN 1

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 7

Conditions

Rectal Neoplasms 7Colorectal Neoplasms 7Colonic Neoplasms 3Pancreatic Neoplasms 1Neoplasms 1Liver Metastasis Colon Cancer 1Carcinoma, Neuroendocrine 1

Interventions

Oxaliplatin 146Fluorouracil 137Capecitabine 121Leucovorin 106Irinotecan 85Radiotherapy 66Bevacizumab 64Cetuximab 46Folfox protocol 27Surgical Procedures, Operative 23Radiation 23Drug Therapy 22Panitumumab 19XELOX 18Chemotherapy, Adjuvant 15Neoadjuvant Therapy 14Radiotherapy, Intensity-Modulated 13Chemoradiotherapy 13Magnetic Resonance Spectroscopy 11regorafenib 10Nivolumab 10Floxuridine 10sintilimab 8raltitrexed 8Specimen Handling 8IFL protocol 8Celecoxib 8Biopsy 8trifluridine tipiracil drug combination 7tislelizumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Rectal Neoplasms × FOLFOXIRI protocol × Clear all
NCT04380337 2025-02-25

Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

Stanford University

Phase 2 Completed
38 enrolled 13 charts
Gastrointestinal

Rectal Neoplasms

NCT02217020 2021-04-14

FORTUNE

Sun Yat-sen University

Phase 2 Completed
100 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03484221 2021-04-14

Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

China Medical University, China

Phase 2 Unknown
30 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04838496 2021-04-09

MEND-IT

Catharina Ziekenhuis Eindhoven

Phase 2 Not yet recruiting
128 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03443661 2021-02-01

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer

ChineseAMS

Phase 2 Completed
50 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03161574 2019-08-08

FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer

Guangxi Medical University

Phase 2 Withdrawn
Gastrointestinal

Rectal Neoplasms

NCT02942563 2018-01-03

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

RenJi Hospital

Phase 2 Unknown
100 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡